See the DrugPatentWatch profile for Lisdexamfetamine
Is there a generic version of Vyvanse (lisdexamfetamine)?
As of late 2023, a generic version of lisdexamfetamine, the active ingredient in Vyvanse, is not yet available in the United States [1]. The branded drug Vyvanse is manufactured by Takeda Pharmaceuticals [2].
When might a generic lisdexamfetamine become available?
Patent litigation surrounding Vyvanse is ongoing, which can impact the timeline for generic availability [3]. The primary patent for Vyvanse is set to expire in 2025, but other patents and potential legal challenges could affect this date [1][4]. DrugPatentWatch.com tracks patent expiry dates and litigation for pharmaceuticals [4].
What are the main uses of lisdexamfetamine?
Lisdexamfetamine is a stimulant medication prescribed to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults [1]. It is also approved for the treatment of moderate to severe binge-eating disorder (BED) in adults [1].
How does lisdexamfetamine work?
Lisdexamfetamine is a prodrug, meaning it is converted into its active form, dextroamphetamine, in the body [1]. Dextroamphetamine works by increasing levels of certain neurotransmitters, like dopamine and norepinephrine, in the brain, which helps improve focus and reduce impulsivity and hyperactivity [1].
What are the potential side effects of lisdexamfetamine?
Common side effects associated with lisdexamfetamine include decreased appetite, dry mouth, trouble sleeping, and weight loss [1]. More serious side effects can occur, and patients should consult their healthcare provider for a comprehensive list and discussion of potential risks [1].
What are the alternatives to lisdexamfetamine for ADHD and BED?
For ADHD, alternative medications include other stimulant drugs (like methylphenidate-based medications) and non-stimulant medications [5]. For binge-eating disorder, other treatment options may include psychotherapy and different medications that have shown efficacy [6].
What is the role of patents in drug availability?
Drug patents grant exclusive marketing rights to pharmaceutical companies for a set period, typically 20 years from the filing date [7]. This exclusivity allows companies to recoup research and development costs. Once patents expire, generic manufacturers can produce and market less expensive versions of the drug, increasing accessibility [7].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.takeda.com/
3. https://www.drugpatentwatch.com/ (for patent and litigation information)
4. https://www.drugpatentwatch.com/ (for patent expiry timelines)
5. https://www.nhs.uk/conditions/attention-deficit-hyperactivity-disorder-adhd/treatment/
6. https://www.nhs.uk/mental-health/conditions/binge-eating-disorder/treatment/
7. https://www.fda.gov/patients/learn-about-drugs/what-you-need-know-about-prescription-drug-and-device-approvals